| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |